A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 776,050 shares of CDMO stock, worth $9.52 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
776,050
Previous 602,850 28.73%
Holding current value
$9.52 Million
Previous $4.3 Million 105.18%
% of portfolio
0.02%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.7 - $12.45 $1.16 Million - $2.16 Million
173,200 Added 28.73%
776,050 $8.83 Million
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $1.74 Million - $2.55 Million
274,400 Added 83.54%
602,850 $4.3 Million
Q1 2024

May 15, 2024

BUY
$5.86 - $8.79 $866,108 - $1.3 Million
147,800 Added 81.82%
328,450 $2.2 Million
Q4 2023

Feb 14, 2024

BUY
$4.64 - $9.56 $673,681 - $1.39 Million
145,190 Added 409.45%
180,650 $1.17 Million
Q3 2023

Nov 14, 2023

SELL
$9.4 - $14.04 $6,486 - $9,687
-690 Reduced 1.91%
35,460 $334,000
Q2 2023

Aug 14, 2023

SELL
$12.96 - $20.93 $707,616 - $1.14 Million
-54,600 Reduced 60.17%
36,150 $505,000
Q1 2023

May 15, 2023

SELL
$13.48 - $18.79 $168,500 - $234,875
-12,500 Reduced 12.11%
90,750 $1.7 Million
Q4 2022

Feb 14, 2023

SELL
$12.61 - $18.74 $197,977 - $294,218
-15,700 Reduced 13.2%
103,250 $1.42 Million
Q3 2022

Nov 14, 2022

SELL
$15.33 - $20.36 $559,545 - $743,140
-36,500 Reduced 23.48%
118,950 $2.27 Million
Q2 2022

Aug 15, 2022

BUY
$11.63 - $21.55 $947,845 - $1.76 Million
81,500 Added 110.21%
155,450 $2.37 Million
Q1 2022

May 16, 2022

SELL
$16.63 - $27.73 $354,219 - $590,649
-21,300 Reduced 22.36%
73,950 $1.51 Million
Q4 2021

Feb 14, 2022

SELL
$20.7 - $34.18 $2.48 Million - $4.09 Million
-119,700 Reduced 55.69%
95,250 $2.78 Million
Q3 2021

Nov 15, 2021

BUY
$19.05 - $28.32 $1.96 Million - $2.92 Million
103,000 Added 92.01%
214,950 $4.64 Million
Q2 2021

Aug 16, 2021

SELL
$18.93 - $25.65 $289,629 - $392,445
-15,300 Reduced 12.02%
111,950 $2.87 Million
Q1 2021

May 17, 2021

BUY
$11.86 - $21.77 $1.15 Million - $2.11 Million
96,900 Added 319.28%
127,250 $2.32 Million
Q4 2020

Feb 16, 2021

BUY
$7.25 - $11.76 $220,037 - $356,916
30,350 New
30,350 $350,000
Q3 2020

Nov 16, 2020

SELL
$6.53 - $8.6 $299,407 - $394,318
-45,851 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$4.11 - $6.78 $34,581 - $57,046
8,414 Added 22.48%
45,851 $301,000
Q1 2020

May 15, 2020

SELL
$3.15 - $7.39 $44,459 - $104,302
-14,114 Reduced 27.38%
37,437 $191,000
Q4 2019

Feb 14, 2020

BUY
$5.01 - $8.16 $258,270 - $420,656
51,551 New
51,551 $395,000
Q4 2018

Feb 14, 2019

SELL
$4.04 - $6.75 $55,578 - $92,859
-13,757 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$4.28 - $7.32 $58,879 - $100,701
13,757 New
13,757 $94,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $763M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.